Tag: MMAe
MMAe reduces poor clinical outcomes or need for surgery twofold in...
Middle meningeal artery embolisation (MMAe) has been shown to result in the twofold reduction of a study endpoint including poor clinical outcomes and need...
Procedural choices matter but vascular penetration has minimal impact on MMAe...
Sub-analyses of two randomised controlled trials (RCTs) have found that, while the extent of vascular penetration appears to have a minimal bearing on outcomes,...
Endovascular Horizons receives Best Abstract Award for transvascular neurosurgery data at...
At this year's Society of Vascular and Interventional Neurology (SVIN) annual meeting (19–22 November, Orlando, USA), Endovascular Horizons received the Best Abstract Award for...
SwiftPAC opens door for standalone coiling in MMA embolisation procedures
NOTE: This video is ONLY available to watch in selected countries and geographies
With his interest in the endovascular treatment of chronic subdural haematoma...
SwiftPAC coil set to create new possibilities in MMA embolisation
This advertorial, intended only for audiences outside the USA, is sponsored by Penumbra.
Following its CE-mark approval and European commercial launch in September this year,...
Weighing up particles, EVOH-based liquid agents and glues in MMA embolisation
With the technique of middle meningeal artery embolisation (MMAe) presently coming of age in chronic subdural haematoma (cSDH) management, Franziska Dorn (Bonn, Germany) outlines...
Microparticle-based MMAe effect size “consistent with other trials” despite failure to...
Middle meningeal artery embolisation (MMAe) involving microparticles—as opposed to liquid embolic agents, glues or coils—did not lead to a statistically significant reduction in six-month...
